Location: Menlo Park, CA
CIK: 0001631134 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 14, 2025
Total Value: $1.829B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| NTRA | Natera Inc | 1,550,280 | $250M | 13.6% | $160.97 | $9.81 | +1512.9% | COM | 632307104 |
| GILD | Gilead Sciences Inc | 1,252,312 | $139M | 7.6% | $111.00 | $99.85 | +12.5% | COM | 375558103 |
| VERA | Vera Therapeutics Inc | 2,793,987 | $81.19M | 4.4% | $29.06 * | $15.35 | +50.6% | CL A | 92337R101 |
| UTHR | United Therapeutics Corp | 190,626 | $79.91M | 4.4% | $419.21 * | $313.03 | +7.4% | COM | 91307C102 |
| JAZZ | Jazz Pharmaceuticals PLC | 588,828 | $77.61M | 4.2% | $131.80 * | $113.27 | +5.9% | SHS USD | G50871105 |
| AZN | AstraZeneca PLC | 823,933 | $63.21M | 3.5% | $76.72 | $74.28 | — | SPONSORED ADR | 046353108 |
| RAPP | Rapport Therapeutics Inc | 1,947,579 | $57.84M | 3.2% | $29.70 * | $23.12 | -22.8% | COM | 75383L102 |
| BSX | Boston Scientific Corp | 569,427 | $55.59M | 3.0% | $97.63 * | $101.76 | +1.8% | COM | 101137107 |
| DXCM | Dexcom Inc | 779,616 | $52.46M | 2.9% | $67.29 * | $77.45 | +2.2% | COM | 252131107 |
| ISRG | Intuitive Surgical Inc | 110,896 | $49.6M | 2.7% | $447.23 * | $507.05 | -5.4% | COM | 46120E602 |
| AXSM | Axsome Therapeutics Inc | 393,499 | $47.79M | 2.6% | $121.45 * | $104.88 | +7.4% | COM | 05464T104 |
| ROIV | Roivant Sciences Ltd | 3,149,270 | $47.65M | 2.6% | $15.13 * | $10.86 | +14.0% | SHS | G76279101 |
| IBB | iShares TR | 325,000 | $46.92M | 2.6% | $144.37 | — | — | Put | 464287556 |
| VRTX | Vertex Pharmaceuticals Inc | 117,875 | $46.16M | 2.5% | $391.64 * | $417.92 | 0.0% | COM | 92532F100 |
| BBIO | BridgeBio Pharma Inc | 831,847 | $43.21M | 2.4% | $51.94 * | $34.41 | +41.7% | COM | 10806X102 |
| UTHR | United Therapeutics Corp | 97,100 | $40.71M | 2.2% | $419.21 * | $313.03 | +7.4% | Put | 91307C102 |
| XBI | SPDR Series Trust | 400,000 | $40.08M | 2.2% | $100.20 | — | — | Put | 78464A870 |
| RNAM | Avidity Biosciences Inc | 875,925 | $38.16M | 2.1% | $43.57 * | $33.95 | +19.1% | COM | 05370A108 |
| ABBV | AbbVie Inc | 150,966 | $34.95M | 1.9% | $231.54 * | $182.67 | +10.6% | COM | 00287Y109 |
| AVBP | Arrivent BioPharma Inc | 1,696,752 | $31.31M | 1.7% | $18.45 * | $20.17 | -2.6% | COM | 04272N102 |
| COGT | Cogent Biosciences Inc | 2,127,941 | $30.56M | 1.7% | $14.36 * | $7.16 | +65.5% | COM | 19240Q201 |
| QURE | Uniqure NV | 500,000 | $29.18M | 1.6% | $58.37 * | $13.65 | +33.0% | Put | N90064101 |
| GKOS | Glaukos Corp | 312,994 | $25.52M | 1.4% | $81.55 * | $91.83 | 0.0% | COM | 377322102 |
| IDYA | IDEAYA Biosciences Inc | 922,695 | $25.11M | 1.4% | $27.21 * | $25.35 | -4.6% | COM | 45166A102 |
| RYTM | Rhythm Pharmaceuticals Inc | 246,966 | $24.94M | 1.4% | $100.99 * | $53.22 | +74.4% | COM | 76243J105 |
| — | Akero Therapeutics Inc | 473,625 | $22.49M | 1.2% | $47.48 | $41.39 | — | COM | 00973Y108 |
| APGE | Apogee Therapeutics Inc | 565,417 | $22.46M | 1.2% | $39.73 * | $38.16 | +0.0% | COM | 03770N101 |
| EXAS | Exact Sciences Corp | 365,000 | $19.97M | 1.1% | $54.71 * | $50.44 | -0.9% | COM | 30063P105 |
| IMTX | Immatics N.V | 2,227,837 | $18.98M | 1.0% | $8.52 * | $5.85 | +5.3% | SHS | N44445109 |
| SMMT | Summit Therapeutics Inc | 900,000 | $18.59M | 1.0% | $20.66 | — | — | Call | 86627T108 |
| PHVS | Pharvaris N V | 739,876 | $18.46M | 1.0% | $24.95 * | $21.08 | +5.2% | COM | N69605108 |
| SUPN | Supernus Pharmaceuticals Inc | 377,066 | $18.02M | 1.0% | $47.79 * | $34.25 | +17.6% | COM | 868459108 |
| QURE | Uniqure NV | 300,000 | $17.51M | 1.0% | $58.37 * | $13.65 | +33.0% | Call | N90064101 |
| RCUS | Arcus Biosciences Inc | 1,222,263 | $16.62M | 0.9% | $13.60 * | $11.15 | -6.7% | COM | 03969F109 |
| — | Merus N V | 166,729 | $15.7M | 0.9% | $94.15 | $52.60 | — | COM | N5749R100 |
| INSM | Insmed Inc | 104,339 | $15.03M | 0.8% | $144.01 * | $51.55 | +137.6% | COM PAR $.01 | 457669307 |
| INBX | Inhibrx Biosciences Inc | 440,092 | $14.82M | 0.8% | $33.68 * | $14.93 | +64.9% | COM | 45720N103 |
| BIOA | BioAge Labs Inc | 2,293,788 | $13.49M | 0.7% | $5.88 * | $20.04 | -76.6% | COM | 09077V100 |
| CELC | Celcuity Inc | 253,375 | $12.52M | 0.7% | $49.40 * | $40.03 | 0.0% | COM | 15102K100 |
| DYN | Dyne Therapeutics Inc | 985,828 | $12.47M | 0.7% | $12.65 * | $16.85 | -32.3% | COM | 26818M108 |
| PTCT | PTC Therapeutics Inc | 186,932 | $11.47M | 0.6% | $61.37 * | $49.90 | +4.4% | COM | 69366J200 |
| GEHC | GE Healthcare Technologies Inc | 151,085 | $11.35M | 0.6% | $75.10 | $74.54 | 0.0% | COM | 36266G107 |
| SLNO | Soleno Therapeutics Inc | 166,281 | $11.24M | 0.6% | $67.60 * | $45.28 | +63.7% | COM | 834203309 |
| PRAX | Praxis Precision Medicines Inc | 172,833 | $9.16M | 0.5% | $53.00 * | $49.76 | -2.6% | COM | 74006W207 |
| SVRA | Savara Inc | 2,427,724 | $8.667M | 0.5% | $3.57 * | $4.16 | -29.0% | COM | 805111101 |
| EWTX | Edgewise Therapeutics Inc | 520,240 | $8.438M | 0.5% | $16.22 * | $16.17 | -12.3% | COM | 28036F105 |
| QURE | Uniqure NV | 136,862 | $7.989M | 0.4% | $58.37 * | $13.65 | +33.0% | SHS | N90064101 |
| ANAB | AnaptysBio Inc | 254,268 | $7.786M | 0.4% | $30.62 * | $17.55 | +30.8% | COM | 032724106 |
| CMPX | Compass Therapeutics Inc | 2,028,886 | $7.101M | 0.4% | $3.50 * | $3.16 | 0.0% | COM | 20454B104 |
| NKTR | Nektar Therapeutics | 118,419 | $6.738M | 0.4% | $56.90 * | $33.10 | 0.0% | COM | 640268306 |
| LQDA | Liquidia Corporation | 250,000 | $5.685M | 0.3% | $22.74 | — | — | Put | 53635D202 |
| — | Cidara Therapeutics Inc | 54,197 | $5.19M | 0.3% | $95.76 | $48.71 | — | COM | 171757206 |
| IMNM | Immunome Inc | 436,051 | $5.106M | 0.3% | $11.71 * | $18.47 | -46.1% | COM | 45257U108 |
| NXTC | Nextcure Inc | 222,654 | $1.305M | 0.1% | $5.86 * | $5.23 | 0.0% | COM | 65343E207 |
| WVE | Wave Life Sciences Ltd | 170,943 | $1.251M | 0.1% | $7.32 * | $7.07 | +14.5% | SHS | Y95308105 |
| SRRK | Scholar Rock Hldg Corp | 31,410 | $1.17M | 0.1% | $37.24 * | $37.92 | -7.8% | COM | 80706P103 |
| JBIO | Jade Biosciences Inc | 107,391 | $927K | 0.1% | $8.63 * | $33.31 | -75.5% | COM | 008064206 |
| IRON | Disc Medicine Inc | 13,553 | $896K | 0.0% | $66.08 * | $50.26 | +18.4% | COM | 254604101 |
| BOLT | Bolt Biotherapeutics Inc | 137,721 | $733K | 0.0% | $5.32 * | $6.62 | -16.2% | COM | 097702203 |
| ACAD | Acadia Pharmaceuticals Inc | 26,800 | $572K | 0.0% | $21.34 * | $23.65 | 0.0% | COM | 004225108 |
| ESTA | Establishment Labs Hldgs Inc | 10,787 | $442K | 0.0% | $40.99 | $47.17 | -13.4% | COM | G31249108 |
| IMA | ImageneBio Inc | 31,884 | $260K | 0.0% | $8.15 * | $13.25 | 0.0% | COM | 45175G207 |